Covered recipient · General Payments record
ERIC J HANAUER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,919.35
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.34 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $321.51 | 13 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $83.04 | 3 |
| ACADIA Pharmaceuticals Inc | $60.19 | 4 |
| ARGENX US, INC. | $56.91 | 3 |
| Amgen Inc. | $34.19 | 2 |
| PFIZER INC. | $22.11 | 1 |
| Amneal Pharmaceuticals LLC | $20.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.09 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872823 | CMS |
| ABBVIE INC. | $7.80 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872825 | CMS |
| ABBVIE INC. | $29.31 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872827 | CMS |
| ABBVIE INC. | $20.11 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872829 | CMS |
| ABBVIE INC. | $11.80 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872831 | CMS |
| ABBVIE INC. | $32.60 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872833 | CMS |
| ABBVIE INC. | $22.45 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872835 | CMS |
| ABBVIE INC. | $34.37 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872837 | CMS |
| ABBVIE INC. | $16.79 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872839 | CMS |
| ABBVIE INC. | $14.08 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872841 | CMS |
| ABBVIE INC. | $29.37 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872843 | CMS |
| ABBVIE INC. | $34.37 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872845 | CMS |
| ABBVIE INC. | $34.37 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103872847 | CMS |
| ACADIA Pharmaceuticals Inc | $14.28 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147973221 | CMS |
| ACADIA Pharmaceuticals Inc | $15.82 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147973226 | CMS |
| ACADIA Pharmaceuticals Inc | $14.58 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147973233 | CMS |
| ACADIA Pharmaceuticals Inc | $15.51 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147973239 | CMS |
| Amgen Inc. | $17.14 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111593806 | CMS |
| Amgen Inc. | $17.05 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111593808 | CMS |
| Amneal Pharmaceuticals LLC | $20.39 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139188174 | CMS |
| ARGENX US, INC. | $19.04 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142111351 | CMS |
| ARGENX US, INC. | $18.32 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142119189 | CMS |
| ARGENX US, INC. | $19.55 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142118754 | CMS |
| Novartis Pharmaceuticals Corporation | $28.46 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086945243 | CMS |
| Novartis Pharmaceuticals Corporation | $25.68 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086945247 | CMS |
| Novartis Pharmaceuticals Corporation | $28.90 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086945249 | CMS |
| PFIZER INC. | $22.11 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131552019 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.